Univfy recognizes the challenges faced by women and men trying to conceive. It is difficult to choose IVF treatment without knowing your IVF success rate, how many treatments it will take, and what is the ultimate IVF cost to have a baby.
The Univfy team helps you to dramatically increase your IVF success rate by having several IVF tries while keeping the IVF costs low. We do that by helping more women qualify for IVF refund programs, which assure that you will conceive or get a refund. We also help your fertility doctor provide the Univfy PreIVF Report* to give you an accurate, personalized IVF treatment success prediction that is based on your own health data and scientifically validated for your doctor's IVF outcomes data.
Founded by experts in reproductive medicine research and biostatistics from Stanford University, Univfy provides the most advanced and scientifically-validated predictive analytics* available, based on your own fertility doctor's IVF outcomes data and our team's experience from analyzing IVF data from over 150,000 IVF treatments and 500,000 embryos.
We aim to help more women use IVF with greater confidence, success, and cost transparency.
"Many women have an excellent chance of having a baby from IVF, if they could only have several tries. We use analytics to make the IVF purchase affordable to more patients by powering providers to offer their own IVF refund programs."
Mylene Yao, M.D.
Co-Founder and CEO
Univfy Inc. is dedicated to helping women realize their dream of having a baby. We are IVF and fertility analytics experts passionate about empowering women to choose IVF with greater confidence, success and cost-success transparency. We power fertility doctors to provide accurate, personalized IVF treatment success prediction to help more women qualify for IVF refund programs so that they can have several tries of IVF without financial risks. The company was founded in 2009 by a research team from Stanford University.
Mylene Yao, M.D. | Co-Founder and CEO
Dr. Yao has led Univfy from founding through stages of technology invention and commercialization. She is now leading the team to scale Univfy's business. Her vision is to combine healthcare AI, fintech, and scientific validation to power women's access to fertility treatments that are safe and highly effective.
Wing H. Wong, Ph.D. | Co-Founder and Advisor
Professor Wong is Professor of Statistics in the Departments of Statistics (former Chairman) and Health Research Policy (Stephen R. Pierce Family Goldman Sachs Professor in Science and Human Health), and by courtesy, the Department of Biology at Stanford University.
Julie Westlund, M.A. | VP of Client Services
Ms. Westlund leads pre/post-sales client services at Univfy. She is an expert marketing and sales lead with over 25 years of experience working with IVF providers and clinic staff covering the US and Canada.
Kristin Shadick, MA | VP of Sales
Mrs. Shadick leads the National Sales Team at Univfy. She oversees Sales, Strategic Initiatives and Provider-Patient Market Expansion.
Kelsey Rush | VP of Product
Ms. Rush leads Product Management, Engineering, and Services Delivery at Univfy. With a career spanning clinical care delivery, digital health, and pharmaceutical research, she has a passion for launching products that leverage the best in technology to improve the delivery of healthcare. A product manager at heart and guided by customer empathy, she will be leading our platform strategy and roadmap to improve the lives of providers, patients, and their families.
Kamal Gelya, MBA | VP of Finance
Mr. Gelya leads Finance at Univfy and is responsible for Univfy's business planning, financial reporting and operations. Prior to Univfy, he was a Finance and Analytics Manager for the Workspace Services Business Unit at Citrix, where he owned strategic planning and business modeling for Service Provider and Citrix Cloud offerings. He is a seasoned BI expert with more than 10 years of consulting experience in Business Intelligence and Analytics domains across various functions and industries.
Chris Hinrichs, Ph.D | Director of Research and Data Science
Dr. Hinrichs leads Univfy's efforts to develop advanced analytics and scale Univfy’s proprietary predictive platform to meet the customized needs of IVF centers powered by Univfy.
Nancy Harrington, RNC-REIN | Director of Clinical Solutions
Ms. Harrington, an accomplished fertility expert and registered nurse in reproductive endocrinology and infertility, has over 27 years of experience in women’s reproductive health.
Univfy Inc., has assembled an international team of renowned fertility researchers and clinical experts to build collaborative research partnerships. This global initiative helps Univfy increase the range of our research opportunities and broaden the impact of our fertility research.
Meet the experts:
Ernesto Bosch, M.D. | Medical Director IVI Valencia, Valencia, Spain
Dr. Ernesto Bosch, Medical Director at the IVI Center Valencia, is a fertility doctor with expertise in IVF and all areas of infertility. He completed medical school at the University of Valencia, Spain in 1992.
Ronald F. Feinberg, M.D., Ph.D | IVF Medical Director Reproductive Associates of Delaware
Dr. Ronald F. Feinberg is one of the Founding Partners of Reproductive Associates of Delaware, where he serves as Medical Director of IVF Programs.
Jamie Grifo, M.D. | Professor and Program Director, NYU Fertility Center, NYU Medical Center, New York, NY
Dr. Jamie Grifo is the Program Director of the New York University (NYU) Fertility Center and since 1995 has been the Director of the Division of Reproductive Endocrinology at the NYU School of Medicine.
Benjamin M. Lannon, M.D. | Specialist in Reproductive Endocrinology & Infertility Boston IVF, Waltham, MA
Dr. Benjamin Lannon, a Reproductive Endocrinologist and infertility specialist, joined Boston IVF in July, 2011.
Arthur Leader, M.D., F.R.C.S.C. | Medical Director Ottawa Fertility Centre
Dr. Arthur Leader has dedicated his life to the reproductive care of the infertile, with a particular interest in assisted human reproduction; he co-founded the IVF program at the Foothills Hospital in 1983.
Marie-Claude Léveillé, Ph.D. | Director of Embryology, Ottawa Fertility Centre
Dr. Marie-Claude Léveillé completed a Bachelor of Science degree in Biochemistry and then earned her PhD in Clinical Sciences, both at the University of Montreal.
Alan M. Penzias, M.D. | Boston IVF Surgical Director & Reproductive Endocrinologist
Dr. Alan S. Penzias is an Associate Professor at the Department of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School, Boston, Massachusetts, Director of the Reproductive Endocrinology and Infertility Fellowship at the Beth Israel Deaconess Medical Center, Boston, Massachusetts and Surgical Director of Boston IVF.
"Most reproductive clinics now offer special financing packages, like discounts for multiple I.V.F. cycles paid upfront, or options to have part of the fee refunded if you don’t become pregnant....Univfy, a company that sells I.V.F. prediction tests, has recently introduced a free online “I.V.F. cost calculator” that uses your probability of becoming pregnant to help you compare the cost of different financing options."
"Univfy’s prediction models actually show more than 60 percent of the women who use them have a higher probability of IVF success than their age-based estimates alone suggest.....I’m Ms. Prepared, so I like the idea of being realistic about what your chances of getting pregnant might be, because IVF always seems to be the great unknown."
"More than seven million people struggle with infertility in this country. Treatments are now widely available, but they can cost tens of thousands of dollars. Now a company based in Los Altos is offering women a personalized predictor of their chances of success with IVF."
"Many women in their late 30s and beyond turn to IVF, usually with little sense of whether the physically demanding and expensive treatments are likely to work. Services like Univfy are trying to help women understand their own fertility better....[Univfy] draws on detailed data from a five-year study of IVF patients and other predictive models to provide personalized information about an individual’s likelihood of conception."